L-4F, an Apolipoprotein A-1 Mimetic, Dramatically Improves Vasodilation in Hypercholesterolemia and Sickle Cell Disease
暂无分享,去创建一个
K. Pritchard | D. Weihrauch | D. Gutterman | K. Guice | C. Hillery | K. Oldham | J. Ou | A. Ackerman | O. Hatoum | Zhi‐jun Ou | Sandra L. Holzhauer | Deron W. Jones | Zhi-Jun Ou
[1] K. Pritchard,et al. L-4F, an Apolipoprotein A-1 Mimetic, Restores Nitric Oxide and Superoxide Anion Balance in Low-Density Lipoprotein-Treated Endothelial Cells , 2003, Circulation.
[2] K. Pritchard,et al. Angiostatin: A Negative Regulator of Endothelial-Dependent Vasodilation , 2003, Circulation.
[3] M. Fishbein,et al. Influenza Infection Promotes Macrophage Traffic Into Arteries of Mice That Is Prevented by D-4F, an Apolipoprotein A-I Mimetic Peptide , 2002, Circulation.
[4] M. Navab,et al. Oxidized lipids as mediators of coronary heart disease , 2002, Current opinion in lipidology.
[5] K. Pritchard,et al. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. , 2002, American journal of physiology. Heart and circulatory physiology.
[6] K. Pritchard,et al. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. , 2002, Free radical biology & medicine.
[7] F. Ruschitzka,et al. High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.
[8] R. Lallone,et al. Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol , 2002, Circulation.
[9] M. Gladwin,et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease , 2002, Nature Medicine.
[10] M. Gladwin,et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] E. Fisher,et al. Elevating High-Density Lipoprotein Cholesterol in Apolipoprotein E—Deficient Mice Remodels Advanced Atherosclerotic Lesions by Decreasing Macrophage and Increasing Smooth Muscle Cell Content , 2001, Circulation.
[12] S. Kaul,et al. Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II , 2001, Circulation.
[13] Jan Nilsson,et al. Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I , 2001, Circulation.
[14] S. Kaul,et al. High-Dose Recombinant Apolipoprotein A-IMilano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E-Deficient Mice: Potential Implications for Acute Plaque Stabilization , 2001, Circulation.
[15] D. Shih,et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[16] G. Anantharamaiah,et al. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. , 2001, Journal of lipid research.
[17] Leslie A. Smith,et al. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[18] R. Hebbel,et al. Amendment history : Erratum ( September 2000 ) Hypoxia / reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice , 2018 .
[19] E. Ellis,et al. Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels. , 2000, Stroke.
[20] J. Berliner,et al. Structural Identification of a Novel Pro-inflammatory Epoxyisoprostane Phospholipid in Mildly Oxidized Low Density Lipoprotein* , 1999, The Journal of Biological Chemistry.
[21] E. Rubin,et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. , 1997, Science.
[22] M. Nieminen,et al. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group. , 1997, Circulation.
[23] H. Bunn. Pathogenesis and treatment of sickle cell disease. , 1997, The New England journal of medicine.
[24] J. Cooke,et al. Arginine Restores Cholinergic Relaxation of Hypercholesterolemic Rabbit Thoracic Aorta , 1991, Circulation.
[25] K. Zitnay,et al. Loss of Selective Endothelial Cell Vasoactive Functions Caused by Hypercholesterolemia in Pig Coronary Arteries , 1988, Circulation research.
[26] K. Bruckdorfer,et al. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta , 1987, Nature.